Gratus Wealth Advisors »

Arrowhead Pharmaceuticals shares owned by Gratus Wealth Advisors

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Gratus Wealth Advisors from 13F filings

Historical chart of Gratus Wealth Advisors investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Gratus Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Gratus Wealth Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $222k 12k 18.13
2024-06-30 $347k 12k 28.30
2024-03-31 $277k 12k 22.61

More positions owned by Gratus Wealth Advisors

Ishares Tr Core Div Grwth (DGRO)
Vanguard World Mega Grwth Ind (MGK)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Ibonds Dec2026 (IBDR)
Ishares Tr Ibonds 27 Etf (IBDS)
Ishares Tr Ibonds Dec25 Etf (IBDQ)
Ishares Tr Ibds Dec28 Etf (IBDT)
Select Sector Spdr Tr Technology (XLK)
Ishares Tr Ibonds Dec24 Etf (IBDP)
First Tr Exchange-traded Cap Strength Etf (FTCS)
First Tr Nas100 Eq Weighted SHS (QQEW)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard World Inf Tech Etf (VGT)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Select Sector Spdr Tr Sbi Healthcare (XLV)

View all positions for Gratus Wealth Advisors

Top funds holding Arrowhead Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Slate Path Capital
T. Rowe Price Investment Management
Geode Capital Management
Siren
Jpmorgan Chase & Co
Morgan Stanley
Northern Trust
Citadel Advisors
Goldman Sachs Group
Charles Schwab Investment Management
Rokos Capital Management

View all funds holding Arrowhead Pharmaceuticals